Preliminary trial of specific targeting therapy against malignant glioma
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference23 articles.
1. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes;Grimm;J Exp Med,1982
2. Lympokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes and natural killer cells;Grimm;J Exp Med,1983
3. Observation on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer;Rosenberg;N Engl J Med,1985
4. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone;Rosenberg;N Engl J Med,1987
5. Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial;Jacobs;Cancer Res,1986
Cited by 223 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bispecific antibodies revolutionizing breast cancer treatment: a comprehensive overview;Frontiers in Immunology;2023-12-04
2. Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment;Frontiers in Immunology;2023-12-01
3. Development of Bispecific Antibody for Cancer Immunotherapy: Focus on T Cell Engaging Antibody;Immune Network;2022
4. Biology and Clinical Evaluation of T/NK Cell Engagers;Cancer Drug Discovery and Development;2022
5. Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics;Cellular & Molecular Immunology;2020-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3